OtoNexus Medical Technologies
Developer of an investigational AI-enabled ultrasound otoscope intended to provide objective, point-of-care assessment of middle-ear conditions. The program combines a miniaturized through-air ultrasound sensor embedded in a disposable speculum tip with automated signal acquisition and AI-assisted analysis, and is advancing clinical validation, regulatory planning (including FDA STeP participation), intellectual-property protection, and commercialization readiness for a capital-equipment plus recurring-consumable business model.
Industries
Nr. of Employees
small (1-50)
OtoNexus Medical Technologies
Bellevue, Washington, United States, North America
Patents
Apparatus and method for characterization of a ductile membrane, surface and sub-surface properties
US-12167936-B2
View Details
Apparatus and method for characterization of a ductile membrane, surface and sub-surface properties
US-12167936-B2
View DetailsProducts
AI-enabled ultrasound otoscope (investigational)
An investigational point-of-care otoscope that combines through-air ultrasound sensing embedded in a disposable speculum tip with automated acquisition and AI-assisted analysis to provide objective information about middle-ear effusion during routine ear exams.
OtoNexus ultrasound otoscope
The first ear check device that provides crucial information about the presence and type of middle ear infection within seconds, enabling clinicians to quickly provide precise, accurate treatment of middle ear infections.
AI-enabled ultrasound otoscope (investigational)
An investigational point-of-care otoscope that combines through-air ultrasound sensing embedded in a disposable speculum tip with automated acquisition and AI-assisted analysis to provide objective information about middle-ear effusion during routine ear exams.
OtoNexus ultrasound otoscope
The first ear check device that provides crucial information about the presence and type of middle ear infection within seconds, enabling clinicians to quickly provide precise, accurate treatment of middle ear infections.
Services
Collaborative clinical research programs with clinical sites to evaluate the investigational ultrasound otoscope and generate performance evidence for regulatory submissions.
Activities to prepare device design, regulatory strategy, manufacturing readiness, and market partnerships for future product introduction.
Collaborative clinical research programs with clinical sites to evaluate the investigational ultrasound otoscope and generate performance evidence for regulatory submissions.
Activities to prepare device design, regulatory strategy, manufacturing readiness, and market partnerships for future product introduction.
Expertise Areas
- Point-of-care diagnostic device development
- Through-air ultrasound transducer R&D
- AI/ML signal processing for medical diagnostics
- Clinical study design and management
Key Technologies
- Through-air ultrasound sensing
- Miniaturized ultrasound transducers
- AI-driven signal analysis
- Embedded sensor-in-speculum design
News & Updates
Company selected for the FDA Safer Technologies Program to facilitate earlier and more frequent engagement with FDA during device development and review.
Admission into the Consortium for Technology & Innovation in Pediatrics (CTIP) accelerator to support pediatric device development and commercialization.
Received National Science Foundation SBIR Phase IIB grant to support ultrasound platform technology development.
Website pages describe through-air ultrasound technology, AI-assisted analysis, planned disposable tip model, and clinical/regulatory activities.
Recognized by Keiretsu networks as a Most Valued Company across multiple investor expos.
Industry recognition for work addressing antibiotic stewardship and infection-control objectives.
Company selected for the FDA Safer Technologies Program to facilitate earlier and more frequent engagement with FDA during device development and review.
Admission into the Consortium for Technology & Innovation in Pediatrics (CTIP) accelerator to support pediatric device development and commercialization.
Received National Science Foundation SBIR Phase IIB grant to support ultrasound platform technology development.
Website pages describe through-air ultrasound technology, AI-assisted analysis, planned disposable tip model, and clinical/regulatory activities.
Recognized by Keiretsu networks as a Most Valued Company across multiple investor expos.
Industry recognition for work addressing antibiotic stewardship and infection-control objectives.